Magnevist side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Magnevist (gadopentetate dimeglumine). Common side effects include nephrogenic systemic fibrosis among females and nephrogenic systemic fibrosis among males.
The phase IV clinical study is created by eHealthMe based on 10,515 reports from the FDA, and is updated regularly.
What is Magnevist?
Magnevist has active ingredients of gadopentetate dimeglumine. eHealthMe is studying from 10,524 Magnevist users. Check the latest studies of Magnevist.
10,515 people who take Magnevist and have side effects are studied.
What are the common side effects of Magnevist, by gender? *
What are the common side effects of Magnevist, by age (0-1 to 60+)? *
What are the common side effects of Magnevist, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Magnevist?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on gadopentetate dimeglumine (the active ingredients of Magnevist) and Magnevist (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Magnevist:
- Magnevist (10,524 reports)
All Magnevist side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ravicti cause The Flu? - 5 seconds ago
- Could Detrol cause Heart Attack? - 11 seconds ago
- Could Pulmozyme cause Croup Infectious? - 11 seconds ago
- Could Nexium cause Transverse Sinus Thrombosis? - 22 seconds ago
- Could Polaramine cause Hot Flush? - 33 seconds ago
- Could Latanoprost cause Swelling? - 36 seconds ago
- Drug interactions of Citalopram Hydrobromide and Magnesium Citrate - 48 seconds ago
- Could Cephalexin cause Broken Bone? - 48 seconds ago
- Could Myfortic cause Osteoarthritis Aggravated? - 56 seconds ago
- Amlodipine vs. Metformin Hydrochloride, side effect and effectiveness comparison - a minute ago